10-K
YEAR END
- Company
- Anixa Biosciences Inc
- Filed
- January 28, 2000
- Period of Report
- October 31, 1999
- Accession Number
- 0000715446-00-000004
A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →